Physician profile
Phuong Ly
NPI 1336717453
$1,353.72
in general payments reported to CMS, 2019-2025
10 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.99 · 2022: $43.08 · 2023: $19.91 · 2024: $1,099 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $295.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,036.37 | 2024-2025 | |
| Boston Scientific Corporation | $98.61 | 2024 | Solyx Sis System |
| Organon LLC | $50.53 | 2025 | |
| Davol INC. | $43.08 | 2022 | |
| Hologic Sales and Service, LLC | $28.11 | 2025 | Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $25.16 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $23.43 | 2025 | |
| Sumitomo Pharma America, INC. | $19.91 | 2023 | Myfembree |
| Ethicon US, LLC | $14.99 | 2021 | |
| Exeltis, USA INC. | $13.53 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuong Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.